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Abstract
Background: Exercise and high-protein/reduced-carbohydrate and -fat diets have each been shown separately, or in
combination with an energy-restricted diet to improve body composition and health in sedentary, overweight (BMI > 25)
adults. The current study, instead, examined the physiological response to 10 weeks of combined aerobic and resistance
exercise (EX) versus exercise + minimal nutrition intervention designed to alter the macronutrient profile, in the absence
of energy restriction, using a commercially available high-protein/low-carbohydrate and low-fat, nutrient-dense food
supplement (EXFS); versus control (CON).
Methods: Thirty-eight previously sedentary, overweight subjects (female = 19; male = 19) were randomly assigned to
either CON (n = 10), EX (n = 14) or EXFS (n = 14). EX and EXFS participated in supervised resistance and endurance
training (2× and 3×/wk, respectively); EXFS consumed 1 shake/d (weeks 1 and 2) and 2 shakes/d (weeks 3–10).
Results: EXFS significantly decreased total energy, carbohydrate and fat intake (-14.4%, -27.2% and -26.7%, respectively;
p < 0.017), and increased protein and fiber intake (+52.1% and +21.2%, respectively; p < 0.017). EX and EXFS significantly
decreased fat mass (-4.6% and -9.3%, respectively; p < 0.017), with a greater (p < 0.05) decrease in EXFS than EX and
CON. Muscle mass increase only reached significance in EXFS (+2.3%; p < 0.017), which was greater (p < 0.05) than
CON but not EX (+1.1%). Relative VO2max improved in both exercise groups (EX = +5.0% and EXFS = +7.9%; p <
0.017); however, only EXFS significantly improved absolute VO2max (+6.2%; p = 0.001). Time-to-exhaustion during
treadmill testing increased in EX (+9.8%) but was significantly less (p < 0.05) than in EXFS (+21.2%). Total cholesterol
and LDL decreased only in the EXFS (-12.0% and -13.3%, respectively; p < 0.017). Total cholesterol-to-HDL ratio,
however, decreased significantly (p < 0.017) in both exercise groups.
Conclusion: Absent energy restriction or other dietary controls, provision of a high-protein/low-carbohydrate and -fat,
nutrient-dense food supplement significantly, 1) modified ad libitum macronutrient and energy intake (behavior effect),
2) improved physiological adaptations to exercise (metabolic advantage), and 3) reduced the variability of individual
responses for fat mass, muscle mass and time-to-exhaustion – all three variables improving in 100% of EXFS subjects.
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Background
The American College of Sports Medicine (ACSM) Posi-
tion Stand, "Appropriate intervention strategies for weight
loss and prevention of weight regain for adults", states
there is little evidence to suggest that exercise-alone is as
effective as energy restriction for promoting weight loss
[1]. Energy restriction-alone is not, however, a sustainable
long-term solution for continued improvements in body
composition and health, and instead it has been reported
that greater than 50% of subjects that lose weight as a
result of dietary restriction-alone eventually regain the
weight,[2]. Chronic adjustments to exercise volume and
intensity, on the other hand, are virtually limitless. In fact,
exercise, in the absence of energy restriction, improves car-
diovascular fitness and body composition in a dose-
dependent fashion; specifically, decreasing body fat and
increasing, or at least preventing significant loss of meta-
bolically active lean body tissue [3].
Another strategy that is gaining support for treating over-
weight and obesity, either when combined with energy
restriction or its absence, is the manipulation of macronu-
trient composition; more precisely, reducing carbohy-
drate (CHO) and increasing protein (PRO) intake to
improve body composition and blood lipids [4-6].
Krieger et al. [4], for example, concluded that, independ-
ent of energy intake, low-carbohydrate/high-protein diets
elicit a metabolic advantage; significantly reducing body
mass (BM), fat mass, percent body fat and retaining signif-
icantly more fat-free mass than diets consisting of greater
than 42% of energy from CHO and ≤ 1.05 g/kg/d PRO,
respectively. Similarly, Krauss et al. [7], which was further
explored by Feinman and Volek [8], showed that in the
absence of energy restriction, a reduction in CHO and
concomitant increase in PRO and dietary fat (FAT)
resulted in significant improvements in BM, total choles-
terol, triglycerides, and total cholesterol-to-high-density
lipoprotein ratio compared to a diet consisting of 54%
CHO, 16% PRO and 30% FAT. Increased satiety and ther-
mogenesis are also commonly reported in response to a
high-protein versus normative-protein (~15% of total
energy from PRO) diet [9].
Furthermore, it has been reported that the use of 1–2
macronutrient- and micronutrient-containing meal
replacements, per day, reduces BM and improves a variety
of disease risk factors in overweight and obese popula-
tions [10]. Such results, however, have been found to be
significantly and positively related solely to the hypoca-
loric state characteristic of said meal replacement inter-
ventions [10]. Nevertheless, a major advantage to the use
of a portion-controlled, nutrient-dense food supplement
appears to be behavioral in nature – their use minimizes
drastic behavior modification and simplifies decision-
making [11], resulting in greater long-term compliance
[10]. Thus, the purpose to our minimal nutrition inter-
vention, controlled design was to assess if provision of a
high-protein/low-carbohydrate and low-fat (~52% PRO,
33% CHO, 15% FAT) nutrient-dense food supplement
(Full Strength®, Phillips Performance Nutrition, LLC,
Golden, CO) would, in the absence of energy restriction,
alter ad libitum macronutrient intake (behavioral effect)
and impose any added metabolic advantage [or detri-
ment] to the physiological effects of 10 weeks of com-
bined aerobic and resistance training in previously
sedentary, overweight men and women.
Methods
Design, subjects and screening
This study involved a minimal nutritional intervention,
controlled design to simulate "real world" use of a high-
protein/low-carbohydrate and low-fat, nutrient-dense
food supplement while participating in a supervised exer-
cise program for 10 weeks. After screening, participants
were randomized into one of three groups: exercise (EX),
exercise plus food supplement (EXFS), or control (CON).
This study was approved by the University of Oklahoma
Institutional Review Board for Human Subjects, and writ-
ten informed consent was obtained from each participant
prior to testing.
Sixty sedentary (< 30 min. physical activity per week),
overweight (BMI ≥ 25) men and women volunteered to
participate in this study. Six subjects were lost from each
of the exercise groups and ten from the CON. Reasons for
attrition included lack of time, unwillingness to consume
the food supplement (FS) and conflicts with work. There-
fore, 38 adult men and women (Table 1) completed the
study. Each participant was assessed by routine medical
screening for inclusion. None of the participants reported
Table 1: Baseline (PRE) descriptive data of the groups (  ± SE).
Variable CON
(n = 10; 5F and 5M)
EX
(n = 14; 7F and 7M)
EXFS
(n = 14; 7F and 7M)
Age (yr) 30.0 ± 1.6 34.8 ± 1.3 32.6 ± 1.6
Height (cm) 171.7 ± 3.9 175.4 ± 2.3 170.2 ± 2.4
Body Weight (kg) 78.3 ± 5.0 82.3 ± 4.1 84.7 ± 5.5
BMI (kg/m2) 26.5 ± 1.4 26.7 ± 1.2 29.2 ± 1.5
CON = control; EX = exercise only; EXFS = exercise + food supplement. No significant differences were observed between groups for height, weight or BMI (p > 0.05).
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or exhibited: (a) A history of medical or surgical events
that may significantly affect the study outcome, including
cardiovascular disease, metabolic, renal, hepatic or musc-
uloskeletal disorders; (b) None of the female participants
were currently pregnant or breast feeding; (c) Use of any
medicine that may significantly affect the study outcome;
(d) Use of nutritional supplements, other than a multi-
vitamin/mineral, in the four weeks prior to the start of the
study; and, (d) Participation in another clinical trial or
ingestion of another investigational product within 30
days prior to screening.
Prior to the start of the 10-week program (PRE), partici-
pants visited the laboratory on two occasions to complete
all body composition, cardiorespiratory, strength and
blood lipid tests. The same measures were performed dur-
ing week 12 (POST), after 10 weeks of training. In addi-
tion, all participants completed 3-day food logs during
PRE and each week of training for a total of 11 weeks.
Each food log included two non-consecutive weekdays
and one weekend day and was used to represent subjects'
average weekly diets. Food logs were analyzed by the same
investigator for total energy (kcal), macronutrients and
fiber (grams), using Food Processor for Windows, Version
8.6 (ESHA Research, Salem, Oregon). Micronutrient
intake was not assessed as part of this investigation.
Measurements
Height (HT) was measured to the nearest 0.5 cm using a
calibrated stadiometer; body mass (BM) was measured
using a calibrated clinical scale to nearest 0.01 kg with par-
ticipants wearing only Spandex shorts or tight-fitting
bathing suit. Serum blood samples were drawn at the Uni-
versity of Oklahoma Goddard Health Center. Samples
were separated by centrifugation and shipped to Labora-
tory Corporation of America (Oklahoma City, OK) for
analysis. All samples were analyzed using established
enzymatic assays for total cholesterol (TC), triglycerides
(TRI) and high-density lipoprotein cholesterol (HDL).
Low-density and very low-density lipoprotein cholesterol
(LDL and VLDL, respectively) were calculated using Fried-
wald's equations [LDL = TC-TRI/2.2; VLDL = TC-
(LDL+HDL)].
Body composition
All body composition assessments were performed on the
same day following a 12-hour fast (ad libitum water intake
was allowed up to one hour prior to testing). Participants
were instructed to avoid exercise for at least 24 hours prior
to testing. Fat mass (FM), percent body fat (%FAT) and
fat-free mass (FFM) were estimated using the five-com-
partment (5-C) model described by Wang et al. [12]:
￿ FM (kg) = 2.748(BV) - 0.715(TBW) + 1.129(Mo) +
1.222(Ms) - 2.051(BM)
￿ %FAT = (FM/BM) × 100
￿ FFM = BM - FM
Where BV is total body volume, TBW is total body water,
Mo is total body bone mineral, Ms is total body soft tissue
mineral, and BM is body mass.
The test-retest reliability for the 5-C equation, as measured
24 to 48 hours apart in 11 men and women, resulted in an
intraclass correlation (ICC) of 0.99 and a standard error of
measurement (SEM) of 0.48%, 0.36 kg and 0.52 kg for
%FAT, FM and FFM, respectively [13]. In addition, there
were no significant differences (p > 0.05) from trial 1 to
trial 2 for %FAT (mean ± SE; 22.0 ± 2.5% to 21.1 ± 2.6%),
FM (15.6 ± 1.8 kg to 14.9 ± 1.9 kg) and FFM (55.9 ± 3.4
kg to 56.7 ± 3.5 kg).
Dual-energy X-ray absorptiometry (DXA) (software ver-
sion 10.50.086, Lunar Prodigy Advance, Madison, WI)
was used to estimate total body bone mineral content and
total body muscle mass (MM). Bone mineral content
(BMC) was converted to Mo using the following equation:
Mo = total body BMC × 1.0436 [12]. In addition, the sum
of lean soft tissue for both arms and legs (ALST), as meas-
ured by DXA, was used to estimate MM from the validated
equation of Kim et al. [14]: MM = (1.13 × ALST) - (0.02 ×
age) + [0.61 × sex (m = 0, f = 1)] + 0.97. Test-retest relia-
bility for MM, as measured 24 to 48 hours apart in 11
male and female subjects resulted in an ICC and SEM of
0.99 and 0.04 kg, respectively [13].
Air displacement plethysmography (BOD POD®, Life
Measurement, Inc., Concord, CA.) was used to estimate
BV. Prior to each test, the BOD POD® was calibrated
according to the manufacturer's instructions with the
chamber empty and using a cylinder of known volume
(49.558 L). The participant, wearing only minimal cloth-
ing (as described earlier) and swimming cap, entered and
sat in the fiberglass chamber. The BOD POD® was sealed,
and the participant breathed normally for 20 seconds
while BV was measured. The participant was then con-
nected to a breathing tube internal to the system to meas-
ure thoracic gas volume, which was used to correct the BV
measurement.
Bioimpedance spectroscopy (BIS) was used to estimate
TBW following the procedures recommended by the man-
ufacturer (ImpediMed SFB7, Queensland, Australia). TBW
estimates were taken while the participant lay supine on a
table with arms ≥ 30 degrees from their torso and legs sep-
arated. Electrodes were placed at the distal ends of the par-
ticipants' right hand and foot. Prior to electrode
placement, excess body hair was removed, and the skin atNutrition & Metabolism 2008, 5:11 http://www.nutritionandmetabolism.com/content/5/1/11
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each site was cleaned with alcohol. Prior to analysis, each
participant's HT, BW, age and sex were entered into the
BIS device. Internal to the device, the BIS utilized 256 fre-
quencies to estimate TBW. The average of two trials within
± 0.05 liters was used to represent each participant's TBW.
The TBW estimate was then used to estimate Ms using the
equation from Wang et al. [12]: Ms = TBW × 0.0129. The
BIS device used in the current study was recently exam-
ined in our laboratory as compared to deuterium oxide for
estimating TBW in a heterogeneous sample of men and
women (n = 30; 23.8 ± 4 yrs; 174.47 ± 7.34 cm; 73.4 ±
18.45 kg; 23.10 ± 5.77 %FAT;   ± SD). The results dem-
onstrated a non-significant constant error (CE = -0.56L, p
> 0.05) and high correlation (r = 0.97), which is similar to
results obtained in other laboratories [15-17]. Therefore,
we feel confident that our BIS device accurately estimated
TBW.
Cardiorespiratory measurements
During a graded exercise test (GXT) on a Quinton® Q65
Series 90 Treadmill (Quinton Instrument Co., Seattle,
WA), respiratory gases were monitored and continuously
analyzed with open-circuit spirometry to calculate minute
ventilation (VE), oxygen consumption rate (VO2), carbon
dioxide expiration rate (VCO2) and respiratory exchange
ratio (RER) using a metabolic cart and manufacturer's
software (True One 2400®, Parvo-Medics, Inc., Provo, UT).
The data were averaged over 30-second intervals. Prior to
each test, the metabolic cart was calibrated using room air
for the flow rate calibration and gases of known volume
and concentration for the calibration of the O2 and CO2
analyzers. The highest 30-second VO2 value during the
GXT was recorded as the maximal oxygen uptake
(VO2max) if it coincided with at least two of the following
criteria: (a) Plateau in heart rate (HR) or HR values within
10% of the age-predicted HRmax; (b) Plateau in VO2
(defined as an increase of not more than 150 ml/min);
and/or, (c) RER value greater than 1.15. Test-retest relia-
bility for VO2max, as measured using 10 male and female
subjects, resulted in an ICC and SEM of 0.98 and 1.17 ml/
kg/min, respectively.
Strength measurements
Each participant completed a 5-repetition maximum
(5RM) for upper- and lower-body strength (bench press
and squat, respectively), using a Cybex®  Plate Loaded
Smith Press (Cybex International, Medway, MA). Each
participant completed a familiarization session prior to
testing. Testing began with a warm-up consisting of 8 to
10 repetitions at approximately 50% of the tester-esti-
mated 5RM load. Following adequate rest of 2 to 3 min-
utes, weight was added and participants attempted five
repetitions through the full range of motion. After each
successful set of five repetitions, the weight was increased
until subjects could no longer complete five repetitions.
Participants rested for 2 to 3 minutes between sets. Test-
retest, for bench press and squat, as measured using 10
male and female subjects, resulted in an ICC and SEM of
0.99, and 0.83 kg and 1.4 kg, respectively.
Training protocol
The exercise program was designed using the American
College of Sports Medicine (ACSM) recommended guide-
lines for apparently healthy adults; all participants were
supervised and trained by an ACSM or National Strength
and Conditioning Association certified trainer. Endurance
training was performed three days per week. Participants
were allowed to select the mode of exercise, provided it
utilized large muscle groups and was rhythmic in nature.
The progressive endurance training program used is sum-
marized in Table 2. Resistance training was performed
two days per week, providing at least 24 hours recovery
between exercise sessions. Participants completed 10 exer-
cises that incorporated all major muscle groups. Each
exercise was performed once per session, and participants
completed 8 to 12 repetitions per exercise until volitional
exhaustion. Weight was increased when participants per-
formed 12 repetitions at the same resistance during two
consecutive lifting sessions. All lifts were performed on
Nautilus Nitro® (Nautilus, Inc., Vancouver, WA) selector-
ized resistance machines.
Nutritional protocol
Participants in the EXFS group were instructed to consume
one FS per day (Full Strength®, Phillips Performance
Nutrition, LLC, Golden, CO) (Figure 1) for the first two
weeks, and two servings per day for the remaining eight
weeks. Subjects were provided a two-week supply of FS at
the end of testing during PRE and at biweekly weigh-ins
throughout the duration of the study. Time of day for con-
suming the FS, as well as how to incorporate the FS into
each subject's diet (i.e. consuming as an additional meal
or in place of another meal), was left to the subject's
choosing. Participants were instructed to mix the FS in 
x
Table 2: Endurance training protocol
Week Duration (min) % Heart Rate Reserve
1 15 – 20 40 – 50
2 20 – 25 40 – 50
3 25 – 30 50 – 60
4 25 – 30 50 – 60
5 25 – 30 60 – 70
6 25 – 30 60 – 70
7 25 – 30 60 – 70
8 30 – 35 60 – 70
9 30 – 35 60 – 70
10 30 – 35 60 – 70Nutrition & Metabolism 2008, 5:11 http://www.nutritionandmetabolism.com/content/5/1/11
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Nutrition Facts and Ingredients of the Food Supplement (Full Strength®, Phillips Performance Nutrition, Golden, CO) Figure 1
Nutrition Facts and Ingredients of the Food Supplement (Full Strength®, Phillips Performance Nutrition, 
Golden, CO). Subjects in EXFS (exercise + food supplement) consumed 1FS/d (Week 1 and 2) and 2FS/d (Week 3–10) in 
combination with ad libitum diet. Participants were free to choose either chocolate- or vanilla-flavored FS. Two-week supplies 
of FS were provided at bi-weekly weigh-ins.Nutrition & Metabolism 2008, 5:11 http://www.nutritionandmetabolism.com/content/5/1/11
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accordance with the label directions. All participants in
CON, EX and EXFS were advised to maintain current (ad
libitum) diet.
Statistical analyses
Separate two-way mixed factorial ANOVAs [group (CON
vs. EX vs. EXFS) × time (PRE vs. POST)] were used to iden-
tify any group × time interactions. If a significant interac-
tion was observed, the statistical model was decomposed
by examining the simple main effects with one-way
repeated measures ANOVAs for each group and one-way
factorial ANOVAs for each time. In the event of significant
simple main effects, Tukey post-hoc comparisons were per-
formed among the groups; all pair-wise comparison
dependent samples t-tests with Bonferroni corrections (p
≤ 0.017) were performed across time. If there was no inter-
action, main effects were analyzed by collapsing across the
non-interacting variable as described above for simple
main effects. The level of significance was set at p ≤ 0.05.
Analyses were performed using SPSS 14.0 (SPSS Inc. Chi-
cago, IL). SPSS-derived p-values of less than 10-3 (i.e., "p =
0.000") are reported in the manuscript as the critical p-
value necessary to obtain significance (i.e., "p ≤ 0.05" or "p
≤ 0.017"). Statistical power calculations demonstrated
power in this investigation ranged from 0.69 to 0.92.
Results
Nutritional profile
Baseline measures, including estimated dietary intake did
not differ (p > 0.05) among subjects in each of the groups
(Table 1 and 3, 4, 5, 6, 7). Estimated mean daily energy
intake did not differ (p > 0.05) between groups, however,
a significant decrease did occur for total energy within
EXFS from PRE to Week 3–10 (-14.4%; p = 0.002); no sig-
nificant changes appeared within EX or CON. Individual
analysis revealed 85.7% (n = 12) of subjects in EXFS
reduced average energy intake by -118.62 to -761.12 kcal/
d, with only two subjects reporting increases from PRE to
Week 3–10; 21.4% (n = 3) of EX subjects reduced energy
intake by -557.87 to -2,184.50 kcal/d (Figure 2). A two-
way interaction (p = 0.001; 1 - β = 0.97) was identified for
mean protein intake from PRE to Week 3–10 (Table 3).
Post-hoc analysis revealed the change in protein intake for
EXFS was significantly greater than EX (+52.1% versus -
9.2%, respectively; p ≤ 0.05). Individual analysis revealed
92.9% (n = 13) of subjects in EXFS increased protein
intake by +31 to +112.13 g/d, whereas EX values ranged
from -68 to +41 g/d (Figure 3). No difference (p > 0.05)
was identified for mean total carbohydrate and fiber
intake among groups; however, a significant decrease (-
27.2%; p = 0.002) in mean daily carbohydrate and an
increase (+21.2%; p ≤ 0.017) in mean daily fiber intake
did occur within EXFS from PRE to Week 3–10, while no
significant changes appeared in EX or CON (Table 3).
Individual analysis revealed that 78.6% (n = 11) of sub-
jects in EXFS reduced mean carbohydrate intake by -52.25
to -173.62 g/d (Figure 4). There was no difference (p >
0.05) for mean daily fat intake among groups; however,
there was a significant decrease in mean daily fat intake
within EXFS from PRE to Week 3–10 (-26.7%; p ≤ 0.017).
Body composition
A significant (p = 0.044; 1 - β = 0.61) main effect for time
was observed across all groups for BM and FFM; however,
Table 3: Average daily energy and macronutrient intake from PRE to Week 1–2 and Week 3–10 (  ± SE).
PRE Week 1–2 Week 3–10
Total Energy Intake (kcal/d)*
CON 2076 ± 168.0 1853 ± 167 1945 ± 66
EX 2039 ± 196.0 2021 ± 127 1951 ± 115
EXFS 2166 ± 160.0 1865 ± 99a 1854 ± 98a
Total Protein Intake (g/d)**
CON 84.1 ± 8.8 90.9 ± 8.8 90.6 ± 11.6
EX 82.4 ± 5.9 75.8 ± 5.2 74.8 ± 5.1
EXFS 86.3 ± 8.5 102.2 ± 3.3 131.3 ± 4.0a,b,c
Total Carbohydrate Intake (g/d)*
CON 253.0 ± 23.1 205.1 ± 19.0 238.0 ± 16.6
EX 268.4 ± 23.1 263.1 ± 19.4 253.5 ± 20.3
EXFS 261.5 ± 20.9 205.0 ± 19.4a 190.3 ± 10.5a
Total Fat Intake (g/d)*
CON 80.9 ± 6.7 74.3 ± 7.0 70.1 ± 5.5
EX 70.6 ± 10.6 73.9 ± 5.7 70.7 ± 4.3
EXFS 86.1 ± 7.7 70.7 ± 4.5a 63.1 ± 4.3a,b
Total Fiber Intake (g/d)**
CON 15.7 ± 1.3 15.3 ± 1.7 16.8 ± 2.1
EX 16.3 ± 1.8 16.5 ± 1.6 15.5 ± 1.8
EXFS 18.9 ± 2.1 19.5 ± 0.8 22.9 ± 0.9a,b
Representative daily intake was calculated as the mean of values as determined from 3-day food logs, recorded weekly by each participant. CON = control; EX = exercise 
only; EXFS = exercise + food supplement. One shake per day, was consumed during Week 1–2; two shakes, per day, were consumed during Week 3–10. *Main effect for 
time (p ≤ 0.05); **Group-by-Time interaction (p ≤ 0.05). aDifferent from PRE (p ≤ 0.017); bDifferent from Week 1–2 (p ≤ 0.05); cDifferent from EX (p ≤ 0.05).
xNutrition & Metabolism 2008, 5:11 http://www.nutritionandmetabolism.com/content/5/1/11
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dependent t-tests showed no significant change for any
single group (Table 4). A two-way interaction (p = 0.002;
1 - β = 0.94) was identified for %FAT and FM from PRE to
POST;  post-hoc  analyses revealed significantly greater
decreases in %FAT and FM for EXFS (-2.5% and -2.7 kg,
respectively; p ≤ 0.05) than in EX (%FAT = -1.2%; FM = -
1.1 kg) and CON (%FAT = -0.4%; FM = -0.4 kg). In addi-
tion, there was a two-way interaction (p = 0.014; 1 - β =
0.77) for MM from PRE to POST. The increase in MM was
significantly (p = 0.05) greater in EXFS (+2.3%) than CON
(0.0%) but did not differ significantly from EX (+1.1%);
EX was not significantly different (p > 0.05) from CON
(Table 4). Individual analysis revealed that 100% (n = 14)
of subjects in EXFS reduced FM (range = -0.62 to -5.3 kg)
and increased MM (range = +0.19 to +1.67 kg); 85.7% (n
= 12) of subjects in EX reduced FM (range = -0.04 to -4.14
kg) and 78.6% increased MM (range = +0.05 to +1.36 kg)
(Figures 5 and 6).
Strength measurements
There was a two-way interaction (p = 0.001; 1 - β = 0.99)
for 5RM strength for both the bench press and squat
(Table 5). Upper- and lower-body strength significantly
improved for EX (+13.2% and +19.6%; p ≤ 0.017) and
EXFS (+17.0% and +22.8%; p ≤ 0.017), with no changes
Table 6: Changes in cardiorespiratory fitness from PRE to POST (  ± SE).
PRE POST CHANGE
VO2max (ml·kg-1·min-1)**
CON 36.8 ± 2.1 36.9 ± 2.0 0.1 ± 0.5
EX 35.7 ± 2.7 37.5 ± 2.4 1.8 ± 0.6a
EXFS 32.9 ± 1.9 35.5 ± 1.8 2.6 ± 0.4a
VO2 (L·min-1)*
CON 2.87 ± 0.25 2.88 ± 0.25 0.01 ± 0.01
EX 2.87 ± 0.23 3.00 ± 0.82 0.13 ± 0.05
EXFS 2.76 ± 0.20 2.93 ± 0.21 0.17 ± 0.04a
Minute Ventilation (L·min-1)*
CON 79.4 ± 7.6 79.0 ± 6.0 0.4 ± 2.5
EX 83.3 ± 5.0 89.1 ± 5.5 5.8 ± 2.4a
EXFS 83.7 ± 4.7 88.0 ± 5.1 4.3 ± 1.4a
Maximum Heart Rate (bpm)*
CON 192.1 ± 2.7 190.9 ± 2.0 -1.2 ± 1.8
EX 190.6 ± 2.6 188.6 ± 2.8 -2.0 ± 1.3
EXFS 187.0 ± 6.2 184.6 ± 6.0 -2.4 ± 1.5
Time-to-Exhaustion (sec)**
CON 643.9 ± 44.8 653.0 ± 46.4 9.1 ± 13.4
EX 681.8 ± 62.0 748.6 ± 65.4 66.8 ± 13.8a,b
EXFS 559.9 ± 46.8 678.6 ± 50.1 118.7 ± 14.3a,b,c
Cardiorespiratory fitness, as assessed by graded treadmill test to exhaustion. CON = control; EX = exercise only; EXFS = exercise + food supplement. *Main effect for time 
(p ≤ 0.05); **Group-by-Time interaction (p ≤ 0.05). aDifferent from PRE (p ≤ 0.017). bDifferent from CON (p ≤ 0.05). cDifferent from EX (p ≤ 0.05).
x
Table 4: Changes in body composition from PRE to POST (  ± 
SE).
PRE POST CHANGE
Body Mass (kg)*
CON 78.2 ± 5.0 77.9 ± 5.0 -0.3 ± 0.5
EX 82.3 ± 4.1 82.0 ± 4.0 -0.3 ± 0.5
EXFS 84.7 ± 5.5 82.9 ± 5.2 -1.8 ± 1.0
Fat Mass (kg)**
CON 22.6 ± 2.0 22.2 ± 2.0 -0.4 ± 0.4
EX 23.9 ± 2.2 22.8 ± 2.9 -1.1 ± 0.4a
EXFS 28.9 ± 2.3 26.2 ± 2.3 -2.7 ± 0.4a,b,c
% Body Fat**
CON 28.9 ± 2.4 28.5 ± 2.6 -0.4 ± 0.4
EX 29.0 ± 2.2 27.8 ± 2.3 -1.2 ± 0.4a
EXFS 34.1 ± 1.3 31.6 ± 1.4 -2.5 ± 0.4a,b,c
Fat-Free Mass (kg)*
CON 55.6 ± 4.3 55.7 ± 4.4 0.10 ± 0.3
EX 58.4 ± 3.5 59.2 ± 3.7 0.80 ± 0.6
EXFS 55.8 ± 3.5 56.7 ± 3.4 0.90 ± 0.5
Muscle Mass (kg)**
CON 26.8 ± 2.5 26.8 ± 2.6 0.0 ± 0.1
EX 28.1 ± 2.2 28.4 ± 2.3 0.3 ± 0.2
EXFS 26.5 ± 2.1 27.1 ± 2.1 0.6 ± 0.1a,b
CON = control; EX = exercise only; EXFS = exercise + food supplement. *Main 
effect for time (p ≤ 0.05); **Group-by-Time interaction (p ≤ 0.05). aDifferent from 
PRE (p ≤ 0.017); bDifferent from CON (p ≤ 0.05); cDifferent from EX (p ≤ 0.05).
x Table 5: Changes in upper- and lower-body strength from PRE to 
POST (  ± SE).
PRE POST CHANGE
Bench Press (kg)**
CON 49.9 ± 8.8 51.3 ± 9.0 1.4 ± 0.4
EX 47.7 ± 7.4 54.0 ± 5.7 6.3 ± 0.8a,b
EXFS 50.0 ± 6.4 58.5 ± 7.2 8.5 ± 1.0a,b
Squat (kg)**
CON 60.9 ± 8.4 61.9 ± 8.0 1.0 ± 0.6
EX 59.2 ± 7.2 70.8 ± 7.3 11.6 ± 1.4a,b
EXFS 61.0 ± 6.9 74.9 ± 7.2 13.9 ± 1.8a,b
Upper- and lower-body strength, as assessed by five-repetition maximum (5RM) 
bench press (upper) and squat (lower). CON = control; EX = exercise only; EXFS 
= exercise + food supplement. *Main effect for time (p ≤ 0.05); **Group-by-Time 
interaction (p ≤ 0.05). aDifferent from PRE (p ≤ 0.017); bDifferent from CON (p ≤ 
0.05).
xNutrition & Metabolism 2008, 5:11 http://www.nutritionandmetabolism.com/content/5/1/11
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(p > 0.05) in CON. No difference (p > 0.05) was evident
between EX and EXFS.
Cardiorespiratory measurements
VO2max (ml/kg/min) improved (p  ≤ 0.017) for EX
(+5.0%) and EXFS (+7.9%), however, no changes were
observed for CON (Table 6). When expressed in absolute
terms (L/min), VO2max increased significantly in EXFS
(+6.2%; p = 0.001), whereas EX demonstrated a non-sig-
nificant (p > 0.017) increase of 4.5%. There was a two-way
interaction (p = 0.001; 1 - β = 0.99) for time-to-exhaustion
(TTE). Post-hoc analysis determined that increases in TTE
Change in Average Daily Energy Intake by Subject Figure 2
Change in Average Daily Energy Intake by Subject. Individual responses for average daily intake of Total Energy from 
Baseline to Week 3–10 (Δ). Exercise + FS (EXFS; left); Exercise-alone (EX; center); Control (CON; right). Dashed line repre-
sents the mean. Total Energy was significantly reduced over time (p ≤ 0.017) in EXFS.
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Table 7: Changes in fasting lipid concentrations from PRE to POST (  ± SE).
PRE POST CHANGE
Total Cholesterol (mg/dL)*
CON 179.8 ± 11.4 173.2 ± 10.9 -6.6 ± 6.6
EX 186.4 ± 7.3 178.2 ± 7.1 -8.2 ± 3.4
EXFS 197.5 ± 10.1 173.9 ± 13.1 -23.6 ± 6.7a
HDL (mg/dL)*
CON 53.9 ± 3.4 51.3 ± 2.4 -2.6 ± 1.8
EX 45.1 ± 2.2 41.9 ± 2.0 -3.2 ± 1.5
EXFS 51.3 ± 4.1 50.9 ± 4.2 -0.7 ± 1.6
LDL (mg/dL)*
CON 107.3 ± 8.7 99.8 ± 8.7 -7.5 ± 4.5
EX 119.7 ± 7.3 112.9 ± 5.8 -6.8 ± 2.7
EXFS 119.5 ± 8.4 103.6 ± 10.5 -15.9 ± 5.2a
TC:HDL*
CON 3.6 ± 0.3 3.3 ± 0.3 -0.3 ± 0.1
EX 4.6 ± 1.3 4.2 ± 1.2 -0.4 ± 0.1a
EXFS 4.2 ± 1.3 3.8 ± 1.2 -0.4 ± 0.1a
VLDL (mg/dL)*
CON 21.2 ± 3.8 20.0 ± 3.1 -1.2 ± 1.8
EX 24.7 ± 3.2 20.9 ± 2.9 -3.8 ± 2.6
EXFS 25.6 ± 3.9 22.3 ± 3.4 -3.3 ± 2.2
Triglycerides (mg/dL)*
CON 106.7 ± 18.6 98.1 ± 13.9 -8.6 ± 8.5
EX 124.0 ± 16.1 104.1 ± 14.4 -19.9 ± 12.9
EXFS 138.0 ± 19.0 111.2 ± 17.0 -26.8 ± 10.0
CON = control; EX = exercise only; EXFS = exercise + food supplement. HDL = high-density lipoproteins; LDL = low-density lipoproteins; TC:HDL = total cholesterol-to-
high-density lipoproteins ratio; VLDL = very low-density lipoproteins. *Main effect for time (p ≤ 0.05). aDifferent from PRE (p ≤ 0.017).
xNutrition & Metabolism 2008, 5:11 http://www.nutritionandmetabolism.com/content/5/1/11
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observed in the EX (+9.8%) and EXFS (+21.2%) groups
were significantly greater (p ≤ 0.05) than changes in CON
(+1.4%); the improvement in TTE was significantly
greater (p ≤ 0.05) in EXFS than EX. Individual analysis
revealed 100% (n = 14) of EXFS improved TTE (+45 to
+210 sec), versus 92.9% (n = 13) of EX (-46 to +147 sec)
and 40% (n = 4) of CON (Figure 7).
Blood lipids
Fasting lipid concentrations are presented in Table 7, and
individual responses for total cholesterol (TC) and triglyc-
erides (TRI) in Figures 8 and 9. TC and low-density lipo-
proteins (LDL) decreased significantly in EXFS (-12.0%
and -13.3%, respectively; p ≤ 0.017), whereas no signifi-
cant changes in TC and LDL were observed in EX or CON.
The TC-to-high-density lipoprotein ratio (TC:HDL)
Change in Average Daily Carbohydrate Intake by Subject Figure 4
Change in Average Daily Carbohydrate Intake by Subject. Individual responses for average daily intake of Carbohy-
drate from Baseline to Week 3–10 (Δ). Exercise + FS (EXFS; left); Exercise-alone (EX; center); Control (CON; right). Dashed 
line represents the mean. Carbohydrate intake was significantly reduced over time (p ≤ 0.017) in EXFS.
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Change in Average Daily Protein Intake by Subject Figure 3
Change in Average Daily Protein Intake by Subject. Individual responses for average daily intake of Protein from Base-
line to Week 3–10 (Δ). Exercise + FS (EXFS; left); Exercise-alone (EX; center); Control (CON; right). Dashed line represents 
the mean. Protein intake was significantly increased over time (p ≤ 0.017) in EXFS, and significantly greater than EX (p ≤ 0.05).
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decreased significantly in both EX and EXFS (-8.7% and -
9.5%, respectively; p ≤ 0.017), with no changes in CON.
Discussion
As hypothesized, consumption of the food supplement
(FS) significantly increased protein (PRO) and fiber
intake in EXFS; PRO rising from 15.9% (86.3 ± 8.5 g/d;
~1.02 g/kg/d) of total energy at baseline (PRE) to 28.3%
(131.3 ± 4.0 g/d; ~1.58 g/kg/d) during weeks 3–10. Simul-
taneously, subjects in EXFS realized a significant decrease
in carbohydrate (CHO), fat (FAT) and total energy. Specif-
ically, CHO decreased from 48.3% (261.5 ± 20.9 g/d) to
41.1% (190.3 ± 10.5 g/d) of total energy; FAT, from
35.8% to 30.6%; and total energy, from 2166 (± 160.0) to
1854 (± 98) kcals/d [Table 3]. The reduction in total
energy intake may be explained by the satiating effect of
Change in Muscle Mass by Subject Figure 6
Change in Muscle Mass by Subject. Individual responses for changes in Muscle Mass from Baseline to Post Week (Δ). Exer-
cise + FS (EXFS; left); Exercise-alone (EX; center); Control (CON; right). Dashed line represents the mean. Muscle Mass 
increased significantly over time (p ≤ 0.017) in EXFS, and was significantly greater than CON (p ≤ 0.05).
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Change in Fat Mass by Subject Figure 5
Change in Fat Mass by Subject. Individual responses for changes in Fat Mass from Baseline to Post Week 3 (Δ). Exercise + 
FS (EXFS; left); Exercise-alone (EX; center); Control (CON; right). Dashed line represents the mean. Fat Mass was significantly 
reduced over time (p ≤ 0.017) in EXFS, and reduced significantly more than EX (p ≤ 0.05).
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PRO and/or fiber [18,19]; though it is our conclusion the
modest increase (+4 g/d) in dietary fiber, albeit statisti-
cally significant, was not a major contributing factor.
Instead, the observed non-significant increase in PRO,
during weeks 1–2, and the significant decrease in CHO,
FAT and energy intake over that same time period in EXFS
would seem to support the separate hypotheses that CHO
or FAT reduction spontaneously reduce energy consump-
tion [20-22]. Such a conclusion runs contrary to findings
by Weigle et al. [23] that increasing PRO-alone elicits a
spontaneous reduction in ad libitum energy intake, or that
only PRO intake, within EXFS, was significantly different
from both control (CON) and EX during weeks 3–10.
Instead, it is proposed that both an increase in dietary
PRO and a reduction in CHO are equally necessary [24];
however, in accordance with our study design, we hypoth-
Change in Total Cholesterol by Subject Figure 8
Change in Total Cholesterol by Subject. Individual responses for changes in Total Cholesterol (TC) from Baseline to Post 
(Δ). Exercise + FS (EXFS; left); Exercise-alone (EX; center); Control (CON; right). Dashed line represents the mean. TC was 
significantly reduced over time (p ≤ 0.017) in EXFS.
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
ѐ
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
 
!
"
#
$
%
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
ѐ
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
ѐ
Change in Time-to-Exhaustion by Subject Figure 7
Change in Time-to-Exhaustion by Subject. Individual responses for Time-to-Exhaustion (TTE) from Baseline to Post (Δ). 
Exercise + FS (EXFS; left); Exercise-alone (EX; center); Control (CON; right). Dashed line represents the mean. TTE increased 
significantly over time (p = 0.001) in EXFS; EXFS was significantly greater than EX and CON (p ≤ 0.05).
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esize that the decrease in CHO was predicated by the ini-
tial increase in PRO. Other possible explanations for the
reduced energy intake are 1) the high viscosity of the
nutritional shake [25], 2) added multivitamin and min-
eral supplementation [26], 3) reduced portion sizes [27],
and/or 4) limiting variety and adding structure to the diet
[28].
It has been well documented that, in the absence of diet-
ing, exercise elicits only minor effects on total body mass
(BM) despite significant improvements in cardiovascular
fitness and strength [29,30]. King et al. ([31] propose that
"inter-individual variability," or behavioral and metabolic
compensatory events in response to exercise-induced
increases in energy expenditure, may largely explain non-
significant changes in BM from exercise-only interven-
tions. In agreement, we found little individual variability
in BM (92.9% of EXFS subjects' ΔBM occurred within
+1.01 and -3.85 kg; 92.9% of EX subjects' ΔBM occurred
within +2.39 and -2.17 kg). Individual responses for ad
libitum energy intake (Figure 2) did, however, provide evi-
dence of what appears to be an apparent trend toward
compensatory increase in energy intake in 57.1% (n = 8)
of subjects in EX but only14.3% (n = 2) of subjects in
EXFS. Consequently, average energy intake was signifi-
cantly reduced within EXFS (Table 3); supportive of the FS
provoking a satiating effect. Additionally, Lofgren et al.
[32] state that even modest changes in BM (<5%), in
response to reduced energy and CHO intake and
increased physical activity, improves cardiovascular
health as assessed by low-density lipoprotein (LDL) cho-
lesterol. In agreement, reductions in LDL only reached sig-
nificance in EXFS (ΔBM = -2.13%; p > 0.05); the only
group within the current study that realized a significant
reduction in energy and CHO intake (Tables 3 and 7).
Expectedly, significant improvements in strength, cardio-
vascular fitness and blood lipids were observed in both EX
and EXFS (Tables 5, 6, 7). Of special note, however, the
change in time-to-exhaustion (TTE), in EXFS, was signifi-
cantly greater than both CON and EX (EXFS = +118.7 sec
> EX = +66.8 sec > CON = +9.1 sec; Table 6), with all sub-
jects in EXFS resulting in a minimum improvement in
fatigue threshold of +45 sec (Figure 7). Speculatively, the
100% improvement rate in TTE, within EXFS, may be
attributable to the rise in muscle mass (MM; +2.3%) and
greater reduction in fat mass (FM) [33], stable blood glu-
cose, hormonal or other physiological adaptation [24],
specific macro- and/or micro-ingredients of the food sup-
plement or improved recovery nutrition between exercise
bouts [34], improved hydration due to twice daily liquid
supplementation, or possibly that the EXFS group was not
blinded to the intervention. Further research controlling
for such variables is warranted.
Interestingly, whereas neither EX or EXFS realized a signif-
icant reduction in plasma triglycerides (-16.1% and -
19.4%, respectively), only EXFS experienced significant
reductions in total cholesterol (-23.6 mg/dL) and LDL (-
15.9 mg/dL) (Table 7 and Figures 8 and 9). The non-sig-
nificant change in triglycerides, within EXFS, is notewor-
thy because the %Δ (-19.4%) is, in fact, consistent with
Change in Triglycerides by Subject Figure 9
Change in Triglycerides by Subject. Individual responses for changes in Triglycerides (TRI) from Baseline to Post (Δ). 
Exercise + FS (EXFS; left); Exercise-alone (EX; center); Control (CON; right). Dashed line represents the mean. TRI did not 
change significantly across treatments (p ≥ 0.05).
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findings involving low-carbohydrate and/or energy-
restricted diets [6,7,32]. One explanation for the non-sig-
nificant change may simply be sample size-dependent,
whereas it is also plausible that EXFS achieved neither a
great enough absolute reduction in CHO and/or energy to
elicit such a response [35]. Layman and Walker [36], on
the other hand, posit that both CHO must be below 150
g/d and PRO greater than 1.5 g/kg/d to elicit effective
treatment against obesity and metabolic syndrome; only
the latter was, in fact, achieved in EXFS (CHO = 190.3 ±
10.5 g/d; PRO ≈ 1.58 g/kg/d).
According to a recent meta-regression by Krieger et al. [4],
the reduction in CHO to <41.4% of total energy and
increase in PRO to >1.05 g/kg/d, observed within EXFS,
can account for the 1.6 kg, 1.3%, 1.5 kg and 0.3 kg greater
improvements in FM, percent body fat, BM and MM
respectively, compared to EX [Note: The regression analy-
sis by Krieger et al. stated an additional 0.60 kg of fat-free
mass was associated with PRO intakes of >1.05 g/kg/d.].
Of particular value is that supplementation with FS
reduced the variability in FM and MM responses to exer-
cise, such that 100% of subjects in EXFS realized a signifi-
cant improvement; a finding that would seem to support
a metabolic advantage of low-carbohydrate/high-protein
diet modification [37]. However, changes in CHO and
PRO alone cannot, in the current study, be viewed in lieu
of modifications in dietary FAT. According to a prediction
equation developed by Astrup et al. [22], 1.17 kg of the
1.8 kg of FM lost by EXFS can be accounted for by the
26.71% reduction in dietary FAT. Thus, it seems prudent
that future research incorporate isocaloric manipulations
of varying macronutrient contributions such that contrib-
uting factors and covariates become more evident.
If, instead, we assume 0.45 kg of FM is equivalent to an
~3500 kcal deficit, the -2.7 kg change in FM, within EXFS,
could almost completely be accounted for by the -312
kcal/d (-14.4%) reduction in energy intake:
Such assumptions, simplified to "calories in versus calo-
ries out," would however fail to recognize the increased
energy demands requisite for the +0.6 kg of MM observed
within EXFS. Instead, a cumulative metabolic advantage,
as postulated by Fine and Feinman [37] and reported by
Scott and Devore [38], combined with the anabolic
response to increased amino acid availability [24,39], and
potentially sustained thyroid hormone levels and reduced
insulin response [6] are more probable mechanisms to
explain the significant mean changes in EXFS body com-
position measures. Layman et al. [39], for example, sug-
gests that a hypocaloric diet with carbohydrate-to-protein
ratio (CHO:PRO, in g/d) of 1.5:1.0 or less would be more
effective in altering body composition than the 3.5:1.0
ratio currently recommended [39]. Consequently, these
authors [39] reported decreases in FM (-22%) and no loss
in lean body mass after 16 weeks of an energy-restricted
diet composed of a CHO:PRO ratio of ~1.5:1.0, during an
exercise program similar to that of the present study.
Meckling and Sherfey [40] postulated similar conclusions
in response to energy restriction and a 1:1 versus a 3:1
CHO:PRO ratio, with or without exercise, in overweight
and obese women. It was reported that both a 1.5:1.0 diet-
only and 0.96:1.00 diet + exercise treatment was more
effective than traditional high carbohydrate, energy
restriction-alone or with exercise. Our findings support
these hypotheses and suggest that addition of the FS to the
EXFS group's ad libitum diet lowered the CHO:PRO ratio
from 3.03:1.00 to 1.46:1.00 for the 10-week training
period and, as described by Wood et al. [21], spontane-
ously reduced ad libitum energy intake via an as of yet fully
understood behavioral effect. This change may have
accounted for the greater improvements and reduced var-
iability of individual responses for FM and MM in EXFS,
when compared to the 3.40:1.00 CHO:PRO ratio of EX.
Another plausible explanation, though not directly
assessed in the current study, may be that subjects in EXFS
consumed one of the FS shakes as a breakfast meal; the
addition of the second shake enabling for more frequent,
protein-rich meals throughout the day. Such would be
supportive of the hypothesis raised by Laymen [24]; that,
consuming a minimum of 30 g of PRO for breakfast is
"the most critical meal" for supporting an anabolic envi-
ronment as is consuming PRO every 5–6 hours.
Conclusion
In summary, in the absence of energy restriction or other
dietary controls, provision of a commercially available
high-protein/low-carbohydrate and fat, nutrient-dense
food supplement (Full Strength®; EXFS), consumed daily,
during a 10-week combined aerobic and resistance train-
ing intervention: 1) elicited a behavioral effect in previ-
ously sedentary, overweight adults such that subjects'
macronutrient profiles were significantly modified (pro-
tein increased; carbohydrate and fat decreased) and total
energy intake decreased spontaneously; 2) physiological
adaptations to exercise were improved; and lastly, 3)
though the significant mean differences between the exer-
cise-only and EXFS groups may not be impressive in the
absolute, consumption of the food supplement reduced
the variability of individual responses for fat mass, muscle
mass and time-to-exhaustion – all three variables improv-
ing in 100% of subjects in EXFS. This is of particular inter-
est because virtually all of the available information
pertaining to the use of food supplement interventions in
overweight and obese populations has involved both an
energy-restricted diet and the methodological replace-
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ment of at least one traditional meal per day [10]. It is rec-
ommended that future research explore the use of the
food supplement under various isocaloric and controlled
macronutrient ratios, as well as assess the potential impact
of the added micronutrients and other ingredients, and
whether or not meal timing and frequency are covariates
to the improvements noted in body composition, fitness
and cardiovascular health.
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